Minocycline-induced cutaneous polyarteritis nodosa with antineutrophil cytoplasmic antibodies

European Journal of Dermatology

Volumn 13, Issue 4, 2003, Pages 396-398

  Pelletier, Fabien ^a   Puzenat, Eve ^a   Blanc, Dominique ^a   Faivre, Brigitte ^a   Humbert, Philippe ^a   Aubin, François ^a  

^a UNIVERSITY HOSPITAL OF BESANÇON   (France)

Author keywords

Antineutrophil cytoplasmic antibody; Minocycline; Polyarteritis nodosa

Indexed keywords

BROMAZEPAM; C REACTIVE PROTEIN; CORTICOSTEROID; FLUOXETINE; MINOCYCLINE; MINOCYNE 50; NEUTROPHIL CYTOPLASMIC ANTIBODY; PREDNISONE;

ACNE; ADULT; ANTIBODY DETECTION; ARTICLE; AUTOIMMUNE DISEASE; CASE REPORT; CORTICOSTEROID THERAPY; DEPRESSION; HUMAN; LIVEDO RETICULARIS; MALE; PATHOPHYSIOLOGY; POLYARTERITIS NODOSA; SKIN BIOPSY; SUBCUTANEOUS NODULE;

ACNE VULGARIS; ADULT; ANTI-BACTERIAL AGENTS; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; DIAGNOSIS, DIFFERENTIAL; DRUG ERUPTIONS; FEMALE; HUMANS; LEG DERMATOSES; MINOCYCLINE; POLYARTERITIS NODOSA;

EID: 0041659224     PISSN: 11671122     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Guillevin L, Lhote F, Gayraud M, Cohen P, Jarrousse B, Lorthoraly O, Thibult N, Casassus P. Prognosis factors in polyarteritis nodosa and Churg-Strauss syndrome: a prospective study in 342 patients. Medicine 1996; 75: 17-28.
2. Begaud B, Evreux JC, Jouglard J, Lagier G. Imputabilité des effets inattendus ou toxiques des médicaments. Actualisation de la méthode utilisée en France. Thérapie 1985; 40: 111-8.
3. Shapiro LE, Knowles SR, Shear NH. Comparative safety of tetracycline, minocycline, and doxycycline. Arch Dermatol 1997; 133: 1224-30.
4. Donnet A, Dufour H, Graziani N, Grisoli F. Minocycline and benign intracranial hypertension. Biomed & Pharmacother 1992; 46: 171-2.
5. Callot V, Roujeau JC, Bagot M, Wechsler J, Chosidow O, Souteyrand P, Morel P, Dubertret L, Avril MF, Revuz J. Drug-induced pseudolymphoma and hypersensitivity syndrome. Arch Dermatol 1996; 132: 1315-21.
6. Gaffney K, Merry P. Antineutrophil cytoplasmic antibody-positive polyarthritis associated with minocycline therapy. Br J Rheumatol 1996; 35: 1327.
7. Elkayam O, Yaron M, Capsi D. Minocycline-induced autoimmune syndromes: an overview. Semin Arthritis Rheum 1999; 28: 392-7.
8. Schlienger RG, Bircher AJ, Meier CR. Minocycline-induced lupus. Dermatology 2000; 200: 223-31.
9. Sturkenboom MC, Meier CR, Jick H, Sticker BH. Minocycline and lupus like syndrome in acne patients. Arch Dermatol 1999; 159: 493-7.
10. Daoud MS, Hutton KP, Gibson LE. Cutaneous periarteritis nodosa: a clinicopathogical study of 79 cases. Br J Dermatol 1997; 136: 706-13.
11. Schaffer J, Davidson D, McNiff J, Bolognia J. Perinuclear antineutrophilic cytoplasmic antibody-positive cutaneous polyarteritis nodosa associated with minocycline therapy for acne vulgaris. J Am Acad Dermatol 2001; 44: 198-206.
12. Schrodt BJ, Callen JP. Polyarteritis nodosa attributable to minocycline treatment for acne vulgaris. Pediatrics 1999; 103: 503-4.
13. Schrodt BJ, Kulp-Shorten CL, Callen JP. Necrotizing vasculitis of the skin and uterine cervix associated with minocycline therapy for acne vulgaris. South Med J 1999; 92: 502-4.
14. Kallenberg CG, Mulder AH, Tervaert JW. Antineutrophil cytoplasmic antibodies: a still-growing class of antibodies in inflammatory disorders. Am J Med 1992; 93: 675-82.
15. Guillevin L, Durand-Gasselin B, Cevallos R, Gayraud M, Lhote F, Callard P, Amouroux J, Casassus P, Jarrousse B. Microscopic polyangiitis: clinical and laboratory findings in 85 patients. Arthritis Rheum 1999; 42: 421-30.
16. Guillevin L, Cohen P, Gayraud M, Lhote F, Jarrousse B, Casassus P. Churg-Strauss syndrome. Clinical study and long-term follow-up of 96 patients. Medicine (Baltimore) 1999; 78: 26-37.
17. Rao JK, Weinberger M, Oddone EZ, Allen NB, Landsman P, Feussner JR. The role of antineutrophil cytoplasmic anti-body (C-ANCA) testing in the diagnosis of Wegener granulomatosis. A literature review and meta-analysis. Ann Intern Med 1995; 123: 925-32.
18. Merkel PA. Drugs associated with vasculitis. Curr Opin Rheumatol 1998; 10: 45-50.
19. Choi HK, Slot MC, Pan G, Weissbach CA, Niles JL, Merckel PA. Evaluation of antineutrophil cytoplasmic cytoplasmic antiboby seroconversion induced by minacycline, sulfalazine, or penicillamine. Arthritis Rheum 2000; 43: 2488-92.
20. Xu X, Zhao M, Zhang Y. Clinicopathological characteristics of propylthiouracil-induced antineutrophil cytoplasmic antibodies-positive vasculitis and their target antigens: a report of 4 cases and literature review. Zhonghua Nei Ke Za Zhi 2002; 41: 404-7.
21. Miller RM, Darben TA, Nedwich J, Savige J. Propylthiouracil-induced antineutrophil cytoplasmic antibodies in a patient with Graves' disease and a neutrophilic dermatosis. Br J Dermatol 1999; 141: 943-4.
22. Angulo JM, Sigal LH, Espinoza LR. Coexistent minocycline-induced systemic lupus erythematosus and auto-immune hepatitis. Semin Arthritis Rheum 1998; 28: 187-92.
23. Jiang X, Khursigara G, Rubin RL. Transformation of lupus-inducing drugs to cytotoxic products by activated neutrophils. Science 1994; 266: 810-3.
24. Dunphy J, Olivier M, Rands AL, Lovell CR, McHugh NJ. Antineutrophil cytoplasmic antibodies and HLA class II alleles in minocycline-induced lupus like syndrome. Br J Dermatol 2000; 142: 461-7.